IRIS
BIANCO, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.166
NA - Nord America 8.450
AS - Asia 6.068
SA - Sud America 945
Continente sconosciuto - Info sul continente non disponibili 467
AF - Africa 73
OC - Oceania 12
Totale 29.181
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.576
US - Stati Uniti d'America 8.277
SG - Singapore 2.010
IE - Irlanda 1.350
CN - Cina 1.167
HK - Hong Kong 1.156
IT - Italia 1.146
VN - Vietnam 898
BR - Brasile 786
GB - Regno Unito 498
UA - Ucraina 458
DE - Germania 438
KR - Corea 301
GR - Grecia 157
FI - Finlandia 148
IN - India 136
FR - Francia 116
TR - Turchia 80
JP - Giappone 78
SE - Svezia 78
CA - Canada 75
AR - Argentina 67
BD - Bangladesh 46
MX - Messico 43
AT - Austria 40
BE - Belgio 36
EC - Ecuador 29
NL - Olanda 29
IQ - Iraq 25
ID - Indonesia 23
UZ - Uzbekistan 20
CH - Svizzera 18
PY - Paraguay 16
ZA - Sudafrica 16
ES - Italia 14
JM - Giamaica 14
PL - Polonia 14
CL - Cile 13
IL - Israele 13
MA - Marocco 13
PH - Filippine 12
PK - Pakistan 12
VE - Venezuela 12
AU - Australia 11
CO - Colombia 11
AE - Emirati Arabi Uniti 10
AL - Albania 9
BJ - Benin 9
CR - Costa Rica 9
SA - Arabia Saudita 9
EG - Egitto 8
PT - Portogallo 8
KE - Kenya 7
TN - Tunisia 7
TW - Taiwan 7
AZ - Azerbaigian 6
EE - Estonia 6
EU - Europa 6
IR - Iran 6
JO - Giordania 6
MY - Malesia 6
NP - Nepal 6
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
LT - Lituania 5
MK - Macedonia 5
PE - Perù 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
NI - Nicaragua 4
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SC - Seychelles 3
TH - Thailandia 3
BG - Bulgaria 2
BH - Bahrain 2
BZ - Belize 2
ET - Etiopia 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
MU - Mauritius 2
QA - Qatar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
Totale 28.704
Salva come PNG Salva come JPEG
Città #
Moscow 3.042
Dublin 1.349
Hong Kong 1.125
San Jose 1.112
Santa Clara 1.017
Jacksonville 813
Chandler 762
Singapore 758
Ashburn 531
Council Bluffs 507
Seoul 296
Ho Chi Minh City 263
Beijing 255
Hanoi 213
The Dalles 190
Princeton 189
Hefei 170
Roxbury 163
Dallas 153
Naples 148
Medford 124
Bremen 123
Los Angeles 123
Milan 101
New York 85
Munich 81
Nuremberg 81
Caserta 80
Bengaluru 71
Cambridge 70
Da Nang 66
Wilmington 65
Des Moines 64
Ann Arbor 62
São Paulo 62
Boardman 61
Helsinki 53
Rome 51
Haiphong 50
Atlanta 37
Brussels 36
Frankfurt am Main 36
Seattle 34
San Mateo 33
Woodbridge 33
Aversa 31
Miano 29
Orem 28
Rio de Janeiro 27
Napoli 25
Phoenix 25
Tokyo 24
Miami 23
Chicago 20
Belo Horizonte 19
Hải Dương 19
Orta di Atella 19
Shanghai 19
Tashkent 19
Dong Ket 18
Guangzhou 18
Jinan 18
Memphis 18
Amsterdam 17
Chennai 16
Norwalk 16
San Francisco 16
Vienna 16
Kochi 15
Mountain View 15
San Giuseppe Vesuviano 15
Brasília 14
Bắc Ninh 14
Columbus 14
Denver 14
Mexico City 14
Montreal 14
Thái Bình 14
Toronto 14
Curitiba 13
Nanjing 13
Biên Hòa 12
Bến Tre 12
Ercolano 12
Guayaquil 12
Baghdad 11
Houston 11
Kingston 11
Kunming 11
New Delhi 11
Ninh Bình 11
Tianjin 11
Warsaw 11
Can Tho 10
Guarulhos 10
Jakarta 10
Manchester 10
Porto Alegre 10
Thái Nguyên 10
Turku 10
Totale 15.607
Salva come PNG Salva come JPEG
Nome #
" Gemcitabine + Vinorelbine (GV) Vs Gemcitabine + Paclitaxel (GT) Vs Gemcitabine (G) Vs Paclitaxel (P) in elderly NSCLC patients". 239
Anticoagulant treatment in COVID-19: a narrative review 219
Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells 218
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 216
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 215
Comorbidities in COPD: Current and Future Treatment Challenges 194
Adiponectin affects lung epithelial A549 cell viability counteracting TNFa and IL-1ß toxicity through AdipoR1 194
Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis 192
Adiponectin in asthma: Implications for phenotyping 190
Adiponectin: An attractive marker for metabolic disorders in chronic obstructive pulmonary disease (COPD) 188
Adiponectin is involved in the control of human lung epithelial A549 cell viability 186
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 186
Evolving concepts in COPDand lung cancer: a narrative review 185
Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2 184
Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease 181
T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis 180
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 177
Integrated therapeutic approach to giant solitary fibrous tumor of the pleura: Report of a case and review of the literature 176
Malattie dell'apparato respiratorio 173
Adiponectin and leptin exert antagonizing effects on huvec tube formation and migration modulating the expression of cxcl1, vegf, mmp‐2 and mmp‐9 170
Adiponectin and its isoforms are overexpressed in COPD patients 169
Descending necrotizing mediastinitis in the elderly patients 169
Aspetti anatomo clinici delle malattie respiratorie 168
Adiponectin as Link Factor between Adipose Tissue and Cancer 167
Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold! 166
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis 165
Clinical characteristics, exercise capacity and pulmonary function in post-covid-19 competitive athletes 164
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 164
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? 162
Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist’s Key Role 160
Asma Bronchiale (recenti acquisizioni sperimentali e contributi personali) 160
Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19 159
Exposure to Submicron Particles (PM1.0) from Diesel Exhaust and Pollen Allergens of Human Lung Epithelial Cells Induces Morphological Changes of Mitochondria Tonifilaments and Rough Endoplasmic Reticulum 158
A chest wall problem. 158
Effectiveness of home-based preoperative pulmonary rehabilitation in COPD patients undergoing lung cancer resection 158
Cardiovascular system in COVID-19: Simply a viewer or a leading actor? 158
EXPLORING THE ROLE OF KREBS VON DEN LUNGEN-6 (KL-6) IN SEVERE TO CRITICAL COVID-19: A SINGLE INSTITUTION EXPERIENCE 157
Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report 156
Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC 155
Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients 154
RFA of primary and metastatic lung tumors: long-term results 154
A biological model to explain the association between human rhinovirus respiratory infections and bronchial asthma 154
Which impact for proton pump inhibitors in SARS-CoV-2 pneumonia 152
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders 152
Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection 151
Effects of diesel exhaust particles on human lung epithelial cells: an in vitro study 149
B-flow twinkling sign in preoperative evaluation of cervical lymph nodes in patients with papillary thyroid carcinoma. 149
Spirometry in elderly laryngectomized patients: A feasibility study 149
Benefi ts of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis 148
Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A CASE REPORT 148
Cardiovascular prosthetic surgery: an analysis of cellular and molecular patterns underlying valve implantation failure. 147
Lung and Nodal Involvement in Nontuberculous Mycobacterial Disease: PET/CT Role 143
Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt? 142
Ruolo dei fattori di crescita nella induzione della proliferazione fibroblastica nella patogenesi della fibrosi polmonare idiopatica 142
Morphology changes in human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM 1.0) and pollen allergens 141
Diagnostic Accuracy of Ultrasound Guided Percutaneous Pleural Needle Biopsy for Malignant Pleural Mesothelioma 140
Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders 139
Routine invasive mediastinal staging of lung cancer in elderly patients without lymph adenopathy on pet-ct scan: Is an appropriate choice? 139
I Farmaci Antiangiogenetici nel Trattamento del Tumore del Polmone 139
Effects of a high-intensity pulmonary rehabilitation program on the minute ventilation/carbon dioxide output slope during exercise in a cohort of patients with COPD undergoing lung resection for non-small cell lung cancer 139
Non-small cell lung cancer presenting as "psoas muscle syndrome": A case report 138
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement 137
Food, nutrition, physical activity and microbiota: Which impact on lung cancer? 137
Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: Focus on sirtuins 136
Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis 135
New insight into adiponectin role in obesity and obesity-related diseases 135
Protective effects of nedocromil sodium on cellular and biohumoral components present in the bronchial alveolar lavage fluid and in peripheral blood in atopic asthmatics 134
Differentially expressed and activated proteins associated with non small cell lung cancer tissues 134
Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study. 134
Altered peptide ligands change T cell repertoire expression in ParJ 1 specific cell lines 134
Effetto antinfiammatorio del sodio nedocromile in pazienti asmatici atopici 133
BARD1: An independent predictor of survival in non-small cell lung cancer 133
COPD and metabolic disorders: role of adiponectin 132
Fractional exhaled nitric oxide-measuring devices: Technology update 131
Interferon-gamma downregulates the rhinovirus induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells 130
Endoscopic treatment of endobronchial carcinoid: technical considerations and experience in interventional pulmonology 129
Disturbi neuropsicologici correlate alla BPCO 129
Raw Bioelectrical Impedance Analysis Variables Are Independent Predictors of Early All-Cause Mortality in Patients With COPD 129
Case report: Selpercatinib in the treatment of RET fusion-positive advanced lung adenocarcinoma: a challenging clinical case 128
Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study 128
Mechanisms of Lung Cancer Development in Cystic Fibrosis Patients: The Role of Inflammation, Oxidative Stress, and Lung Microbiome Dysbiosis 126
Inflammatory effects on human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM₁.₀) and pollen allergens. 126
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment 126
Frailty in Patients With Lung Cancer: A Systematic Review and Meta-Analysis 125
Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents 124
Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention 124
IFNY TRIGGERS APOPTOSIS IN VITRO M.T. ACTIVATED ALVEOLAR MACROPHAGES 124
Anti-inflammatory effects of adiponectin in A549 cells exposed to TNF alpha and IL-1 beta 124
Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease 123
Exploring the role of serum adiponectin and its holigomerization in fibrotic interstitial lung diseases: results from a cross-sectional study 122
High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis 122
Distinct BARD1 isoforms expressed in lung cancer potential targets for treatment 121
Somatostatin-Dependent Regulation of Alveolar Macrophages Activation and Cytokine Production 121
Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis 121
The burden of obesity in asthma and COPD: Role of adiponectin 120
Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management 120
Impact of Triple Inhaler Therapy on COPD Patients with Non-Small Cell Lung Cancer After Radical Surgery: A Single-Centre Retrospective Analysis 119
CORRELATION BETWEEN CHEMICAL MEDIATORS AND HAEMORHEOLOGICAL - COAGULATIVE FACTORS IN THE PATHOGENESIS OF CHRONIC RESPIRATORY FAIL¬URE CAUSED BY INTERSTITIAL LUNG DISEASES (F.I.D) 119
Anti-inflammatory effect of sodium nedocromil in atopic asthmatic patients|EFFETTO ANTIINFIAMMATORIO DEL SODIO NEDOCROMILE IN PAZIENTI ASMATICI ATOPICI 118
Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension 118
Totale 15.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.052 0 0 0 14 380 14 25 29 60 50 79 401
2022/20232.778 233 52 19 251 320 245 46 179 1.293 29 57 54
2023/20241.132 91 36 61 86 365 67 19 23 16 33 154 181
2024/20254.235 27 83 32 105 626 591 644 343 544 622 392 226
2025/202614.824 517 608 759 675 1.174 7.872 1.145 765 674 284 223 128
2026/20272.242 111 455 1.093 583 0 0 0 0 0 0 0 0
Totale 29.181